The Injectables Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017,analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.
Growth of biologics and entry of biosimilars in leading pharma markets such as the U.S. and Europe is expected to be the key driver for growth of the injectable drug delivery market for the forecast period (2010-2015).
Driven by above mentioned factors, the global injectable drug delivery market is expected to grow from $14,994 million in 2009 to $29,981 million in 2015 at a CAGR of 12.3% during 2010-2015.
Do Inquiry Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=150
Globally, injectable medications form the second most preferred class of drugs, with oral route of administration leading the global pharma market. Injectable drug delivery devices have evolved from traditional needles and syringes to recently developed needle-free injectors. The market has evidenced a shifting trend from administration of injections in clinician settings to home care settings, which has resulted in increasing the focus of industry players towards the development of user friendly and patient compliant devices.
Download Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=150
On the drug delivery formulation front, novel drug delivery technologies and applications of nanotechnology have resulted in the development of targeted drug delivery carriers such as liposomes, microspheres and polymeric micelles. PEGylation of these nanoparticles enables sustained release of drugs at the target site. Rising need of targeted and sustained drug delivery in the treatment of chronic diseases and need of cost efficient delivery of high priced medications is expected to drive this market.
The key players in this market are Becton Dickinson & Co. (U.S.), Baxter International, Inc. (U.S.), SHL Group (Taiwan), Ypsomed Holding AG (Switzerland), Terumo Corporation (Japan) and Schott AG (Germany), Owen Mumford Ltd (U.K.), and Antares Pharma, Inc. (U.S.).
Request for Free 10% Customization of Report @ http://www.marketsandmarkets.com/requestCustomization.asp?id=150
Browse Related Reports:
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn@ http://www.linkedin.com/company/marketsandmarkets